Clinical Trial Update: Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy [NA]

View source ↗

Summary

A completed clinical trial evaluating the role of the anti-mouse PLA2R1 ELISA in membranous nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Anti-mouse PLA2R1 ELISA (Anti-mouse PLA2R1 ELISA)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Membranous Nephropathy | NA | Status: COMPLETED